The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 yearsThe Status of Irritability in Psychiatry: A Conceptual and Quantitative ReviewDisruptive mood dysregulation disorder: a new diagnostic approach to chronic irritability in youthIs bipolar always bipolar? Understanding the controversy on bipolar disorder in childrenDisruptive mood dysregulation disorder: current insightsA novel group therapy for children with ADHD and severe mood dysregulation.Helping Children Hospitalized for Rages.Two-sample density-based empirical likelihood ratio tests based on paired data, with application to a treatment study of attention-deficit/hyperactivity disorder and severe mood dysregulationTreatment Options for the Cardinal Symptoms of Disruptive Mood Dysregulation DisorderEarly psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial.Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorderDo we really know how to treat a child with bipolar disorder or one with severe mood dysregulation? Is there a magic bullet?Irritability in children and adolescents: past concepts, current debates, and future opportunities.A Randomized Clinical Trial of an Integrative Group Therapy for Children With Severe Mood Dysregulation.Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study.Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.Disruptive Mood Dysregulation Disorder Symptoms and Association with Oppositional Defiant and Other Disorders in a General Population Child Sample.The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.Recent advances in understanding the personality underpinnings of impulsive behavior and their role in risk for addictive behaviors.Hyperactivity and sensation seeking as autoregulatory attempts to stabilize brain arousal in ADHD and mania?ADHD and Emotion Dysregulation Among Children and Adolescents.Evidence-based treatments for youths with severely dysregulated mood: a qualitative systematic review of trials for SMD and DMDD.Morning light therapy for juvenile depression and severe mood dysregulation: study protocol for a randomized controlled trial.The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.Practitioner Review: Definition, recognition, and treatment challenges of irritability in young people.Stability of Disruptive Mood Dysregulation Disorder Symptoms (Irritable-Angry Mood and Temper Outbursts) Throughout Childhood and Adolescence in a General Population Sample.The affective storms of school children during night time: do affective dysregulated school children show a specific pattern of sleep disturbances?Effects of Folic Acid on Appetite in Children with Attention Deficit Hyperactivity Disorder (ADHD) Treated with Methylphenidate: A Randomized Double-Blind Clinical Trial.Executive impairment determines ADHD medication response: implications for academic achievement.Psychosocial Treatment of Irritability in Youth
P2860
Q22061981-174F6B1C-B53F-488A-8CF0-8D3BDFF452F5Q24234231-2B8791DD-18F5-4BBC-81D7-4A15E3C8821EQ26747136-F51F4B3D-EFDF-4BEA-8EC2-D6F100C05E4AQ27009447-C3DAD22B-3E46-4DC2-BA6D-EF230E634BC7Q27011821-6A8D568F-1BBA-43DF-A95C-DDA6A7CD866CQ28069569-5BE5B9EF-262E-4ACF-8677-5FBB00559194Q33820624-3ABAF429-6E10-419C-9B8A-3D2968EE3AE9Q34111063-CCCD2DA8-7961-4CBF-BAE9-6E781739684FQ34309538-77EBECC8-C0BA-48E0-91F6-A2E08A217F40Q34492314-1D677600-77F5-4082-954B-8EEBBD4219EBQ34802696-155D128B-4669-4CC7-B9A9-BE0CB8E31A18Q35486056-32153087-7F67-49E0-9DC6-460895532239Q35607178-DE630D8A-BDEC-4D87-B75E-0829A3CC3AB1Q35751499-8DAE88D6-B996-4A52-BA82-285D503C5265Q36610730-89F6C9F6-08F4-47B3-A07A-067151E86AA8Q36635758-79772D79-B4BF-455D-9291-6C6654B58203Q36687442-17386FFF-A2B6-4FB7-A9D3-8EBF98963331Q36707991-19B2F9A9-4CF9-4D1A-9A8A-FE7561171157Q36707994-4FCDB4A7-29CD-4D0A-98F6-F66FF709ADD7Q37523029-634D98AE-D9D4-45F7-9384-9703FEA7DD2AQ37638323-7914AE3D-4A74-412B-AA5B-B9FFA9BA731CQ38226620-4CB83C0F-CAD3-42A3-B516-54B0E803E2B7Q38561013-F0717F8C-3E08-47A6-B886-0A6FAE29756AQ38818252-CBC2C86B-EA9C-425E-9EED-79018C47AF97Q42121078-03E3CADC-F96A-437F-B041-57972FD8D24BQ43889522-C307DBAC-3CB8-466D-98E7-466A5B996DC8Q47586182-DA0AB5C6-8CBF-4247-9FE9-E306C30AD116Q47695329-2C2F8BF5-9003-4430-87C5-F92876CDDAC2Q48239293-94C2DBFD-318E-40E0-81AC-2D83B5800935Q49338753-56155890-74E4-43E2-ADD7-CBE65F05714AQ51017656-E22CD6BC-A585-4C72-AF4A-D72B1DA4F9C5Q57497915-D3F8BB3A-DC77-46FA-8E3C-FE0B7F1C9BFB
P2860
The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The efficacy and tolerability ...... and severe mood dysregulation.
@en
The efficacy and tolerability ...... and severe mood dysregulation.
@nl
type
label
The efficacy and tolerability ...... and severe mood dysregulation.
@en
The efficacy and tolerability ...... and severe mood dysregulation.
@nl
prefLabel
The efficacy and tolerability ...... and severe mood dysregulation.
@en
The efficacy and tolerability ...... and severe mood dysregulation.
@nl
P2093
P2860
P50
P356
P1476
The efficacy and tolerability ...... and severe mood dysregulation.
@en
P2093
Allison C Garefino
Antara Majumdar
Briannon O'Connor
Elizabeth Gnagy
Frances W Arnold
Gregory A Fabiano
James Waxmonsky
Jessica A Robb
Jessica Verley
Kathryn S Walker
P2860
P304
P356
10.1089/CAP.2008.065
P577
2008-12-01T00:00:00Z